GUMMADI, Venkateshwar Rao,SAMAJDAR, Susanta,NELLORE, Kavitha,DAGINAKATTE, Girish,BALASUBRAMANIAN, Wesley Roy
申请号：
IBIB2018/052232
公开号：
WO2018/178947A2
申请日:
2018.03.30
申请国别(地区):
IB
年份:
2018
代理人:
摘要：
The present invention provides methods for treating hematological disorders, such as acute myeloid leukemia, by the use of substituted heterocyclic compounds and pharmaceutically acceptable salts thereof. The compounds inhibit IRAK4 and FLT-3 kinases.
